Intravenous Tirofiban Infusion After Angioplasty and Stenting in Intracranial Atherosclerotic Stenosis-Related Stroke

医学 替罗非班 改良兰金量表 血管成形术 血肿 优势比 闭塞 外科 冲程(发动机) 狭窄 麻醉 内科学 缺血 心肌梗塞 缺血性中风 工程类 经皮冠状动脉介入治疗 机械工程
作者
Byung Hyun Baek,Woong Yoon,Yun Young Lee,Seul Kee Kim,Joon‐Tae Kim,Man‐Seok Park
出处
期刊:Stroke [Lippincott Williams & Wilkins]
卷期号:52 (5): 1601-1608 被引量:55
标识
DOI:10.1161/strokeaha.120.033551
摘要

This study aimed to investigate the effectiveness and safety of intravenous infusion of tirofiban after emergent angioplasty with or without stenting in patients with intracranial atherosclerotic stenosis-related large-vessel occlusion stroke.We performed a retrospective case series study of 98 patients who underwent thrombectomy followed by angioplasty with or without stenting to treat intracranial atherosclerotic stenosis-related large-vessel occlusion. Patients were divided into 2 groups: those who received continuous intravenous infusion of tirofiban for 12 hours after procedure (intravenous tirofiban group, n=30) and those who did not receive postprocedural intravenous tirofiban (control group, n=68). The following treatment outcomes in the 2 groups were compared: early reocclusion of treated arteries on computed tomography angiography, parenchymal hematoma, symptomatic hemorrhage, and 90-day functional outcome.Early reocclusion occurred in 18 patients (18.4%). The rate of early reocclusion was significantly lower in the intravenous tirofiban group than in the control group (3.3% versus 25%, P<0.001). The rates of parenchymal hematoma, symptomatic hemorrhage, 90-day good outcome, and mortality were not significantly different between the 2 groups. In multivariate logistic analysis, the only independent predictor of early reocclusion was no use of intravenous tirofiban (odds ratio, 9.212 [95% CI, 1.155-73.495], P=0.036). A good outcome (90-day modified Rankin Scale score of 0-2) was significantly less frequent in patients with early reocclusion than in those without it (16.7% versus 72.5%, P<0.001).The use of intravenous tirofiban for 12 hours was associated with decreased risk of early reocclusion of treated arteries, with no increased risk of hemorrhage after emergent angioplasty, with or without stenting, in patients with intracranial atherosclerotic stenosis-related large-vessel occlusion stroke. Early reocclusion was associated with a poor outcome in such cases.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
凉拌卡布奇诺完成签到,获得积分20
刚刚
汉堡包应助ZYY采纳,获得10
刚刚
CodeCraft应助ZYY采纳,获得10
刚刚
ding应助ZHOU采纳,获得10
1秒前
ComeOn发布了新的文献求助10
1秒前
慎二完成签到 ,获得积分10
1秒前
小二郎应助Dr.c采纳,获得10
1秒前
ZhaohuaXie应助gjww采纳,获得10
1秒前
2秒前
2秒前
斯文败类应助科研通管家采纳,获得10
2秒前
隐形曼青应助科研通管家采纳,获得10
2秒前
ghostR应助Morin采纳,获得10
2秒前
JamesPei应助科研通管家采纳,获得10
2秒前
2秒前
2秒前
Lucas应助科研通管家采纳,获得10
2秒前
3秒前
3秒前
3秒前
乐乐应助科研通管家采纳,获得10
3秒前
3秒前
3秒前
科研通AI2S应助科研通管家采纳,获得10
3秒前
大模型应助科研通管家采纳,获得20
3秒前
彭于晏应助科研通管家采纳,获得10
3秒前
小二郎应助科研通管家采纳,获得10
3秒前
乐乐应助科研通管家采纳,获得10
3秒前
3秒前
4秒前
4秒前
一切皆有利于我完成签到 ,获得积分10
4秒前
852应助科研通管家采纳,获得10
4秒前
科目三应助科研通管家采纳,获得10
4秒前
充电宝应助科研通管家采纳,获得10
4秒前
4秒前
慕青应助傻子与白痴采纳,获得10
4秒前
蜂蜜发布了新的文献求助10
6秒前
vvvv发布了新的文献求助100
6秒前
科研通AI6.3应助14采纳,获得10
6秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
48V Low-voltage Power Distribution Network (PDN) Architecture Industry Report, 2024 800
ズームレンズの光学設計に関する研究 800
Fundamentals of Pharmaceutical and Biologics Regulations: A Global Perspective, Second Edition 700
Matrix Methods in Data Mining and Pattern Recognition Second Edition 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7296028
求助须知:如何正确求助?哪些是违规求助? 8914253
关于积分的说明 18875694
捐赠科研通 6962179
什么是DOI,文献DOI怎么找? 3210366
关于科研通互助平台的介绍 2379631
邀请新用户注册赠送积分活动 2186675